Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Breaks Ground on New Facility in India to Support Local Pharmas

NEW YORK (GenomeWeb News) — Thermo Fisher Scientific has broken ground on a $17 million facility in India designed to support its biopharmaceutical customers in the country.
 
Thermo Fisher said the 100,000-square-foot facility, located in the western city of Ahmadabad, will be responsible for packaging, distributing, and managing logistics for pharmaceutical samples that will be part of drug trials around the world.
 
The company expects to open the facility in the spring of 2008 and add approximately 100 employees in the first year of operation.
 
"Large pharmaceutical companies are focusing more and more on India for their future clinical research and development programs," Thermo Fisher CEO Marijn Dekkers said in a statement.
 
"They are looking to outsource their clinical trials management to partners who know how to work within changing regional and global clinical trial regulations,” he added.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.